Viewing posts from: November 2017

AZTherapies, Inc. appoints Karen Reeves, MD as President and Chief Medical Officer

Posted by bwg in Press Release | 0 comments

BOSTON, Oct. 31, 2017 /CNW/ -- Former Pfizer executive joins AZTherapies focused on Alzheimer's Disease, ischemic stroke, and other neurological diseases by creating novel treatments for neurodegeneration and neuroinflammation. AZTherapies, Inc. is a privately held advanced clinical stage pharmaceutical company located in Boston, MA that is developing breakthrough treatments for Alzheimer's disease, ischemic stroke, and other neurological diseases associated with neurodegeneration and neuroinflammation. The lead product candidate, a combination therapy treatment of two re-engineered drugs, ALZT-OP1, is being studied in a Phase 3 Early Alzheimer's clinical trial, the COGNITE trial.